A simultaneous [11C]raclopride positron emission tomography and functional magnetic resonance imaging investigation of striatal dopamine binding in autism.
Nicole R ZürcherErin C WalshRachel D PhillipsPaul M CernasovChieh-En Jane TsengAyarah DharanikotaEric SmithZibo LiJessica Lynn KinardJoshua C BizzellRachel K GreeneYuen-Siang AngDiego A PizzagalliDavid Izquierdo-GarciaKinh TruongDavid LalushJacob M HookerGabriel Sviatoslav DichterPublished in: Translational psychiatry (2021)
The social motivation hypothesis of autism posits that autism spectrum disorder (ASD) is characterized by impaired motivation to seek out social experience early in life that interferes with the development of social functioning. This framework suggests that impaired mesolimbic dopamine function underlies compromised responses to social rewards in ASD. Although this hypothesis is supported by functional magnetic resonance imaging (fMRI) studies, no molecular imaging study has evaluated striatal dopamine functioning in response to rewards in ASD. Here, we examined striatal functioning during monetary incentive processing in ASD and controls using simultaneous positron emission tomography (PET) and fMRI. Using a bolus + infusion protocol with the D2/D3 dopamine receptor antagonist [11C]raclopride, voxel-wise binding potential (BPND) was compared between groups (controls = 12, ASD = 10) in the striatum. Striatal clusters showing significant between-group BPND differences were used as seeds in whole-brain fMRI general functional connectivity analyses. Relative to controls, the ASD group demonstrated decreased phasic dopamine release to incentives in the bilateral putamen and left caudate, as well as increased functional connectivity between a PET-derived right putamen seed and the precuneus and insula. Within the ASD group, decreased phasic dopamine release in the putamen was related to poorer theory-of-mind skills. Our findings that ASD is characterized by impaired striatal phasic dopamine release to incentives provide support for the social motivation hypothesis of autism. PET-fMRI may be a suitable tool to evaluate novel ASD therapeutics targeting the striatal dopamine system.
Keyphrases
- functional connectivity
- autism spectrum disorder
- resting state
- positron emission tomography
- computed tomography
- intellectual disability
- uric acid
- attention deficit hyperactivity disorder
- magnetic resonance imaging
- healthcare
- pet ct
- prefrontal cortex
- pet imaging
- mental health
- randomized controlled trial
- metabolic syndrome
- magnetic resonance
- parkinson disease
- dna binding
- small molecule
- binding protein
- hepatitis c virus
- brain injury
- multiple sclerosis
- human immunodeficiency virus
- drug delivery
- blood brain barrier
- case control
- hiv infected
- cerebral ischemia